New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2014
07:46 EDTSRPTSarepta price target raised to $35 from $22 at RW Baird
Baird raised its price target on Sarepta following its update on pulmonary data that provides incremental evidence of efficacy of its 6MWT results from last month. The firm expects the next catalyst to be clarity on its pivotal trial design. Shares are Outperform rated.
News For SRPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SRPT

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use